Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Finance
Payers
Regulatory
Special Reports
Podcasts
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Whitepapers
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Finance
Payers
Regulatory
Special Reports
Podcasts
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurology
Health Tech
2023 forecast: Alzheimer's drugs ignite health tech arms race
With lecanemab expected to enter the market next year, health tech companies are finding ways to decrease friction in the Alzheimer's treatment path.
Annie Burky
Dec 21, 2022 5:00am
Where digital health investors plan to place their bets in 2023
Dec 2, 2022 7:00am
Blues plans pass on including aducanumab on formulary
Aug 16, 2021 3:15pm
CMS should act quickly on coverage for Biogen's Alzheimer's drug
Jun 7, 2021 4:00pm
SOC Telemed acquires acute care telehealth company for $194M
Apr 1, 2021 7:10am
COVID-19 pandemic accelerates use of tele-neurorehabilitation
Jan 26, 2021 10:21am